Zanamivir, Relenza…For the prevention and treatment of influenza A and B.

Posted on

New Drug Approvals

 

 

Zanamivir

 

139110-80-8

 

APPROVED 26-7-96……. GSK NDA 021036

 

A guanido-neuraminic acid that is used to inhibit neuraminidase.

READ AT

http://www.allfordrugs.com/2014/02/02/zanamivir-relenza-for-the-prevention-and-treatment-of-influenza-a-and-b/

 

View original post

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s